CCT129202

CCT129202
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T6435-1mg 1 mg

7 - 10 business days*

40.00€
TGM-T6435-2mg 2 mg

7 - 10 business days*

55.00€
TGM-T6435-5mg 5 mg

7 - 10 business days*

81.00€
TGM-T6435-10mg 10 mg

7 - 10 business days*

148.00€
TGM-T6435-25mg 25 mg

7 - 10 business days*

264.00€
TGM-T6435-50mg 50 mg

7 - 10 business days*

424.00€
TGM-T6435-100mg 100 mg

7 - 10 business days*

627.00€
TGM-T6435-500mg 500 mg

7 - 10 business days*

1,350.00€
 
Description: CCT129202 is an ATP-competitive pan-Aurora inhibitor for Aurora A, Aurora B and... more
Product information "CCT129202"
Description: CCT129202 is an ATP-competitive pan-Aurora inhibitor for Aurora A, Aurora B and Aurora C with IC50 of 0.042 µM, 0.198 µM and 0.227 µM, respectively. It is less potent to FGFR3, GSK3beta, PDGFRbeta, etc. Target: Aurora Kinase. Smiles: CN(C)c1ccc(cc1)-c1nc2c(N3CCN(CC(=O)Nc4nccs4)CC3)c(Cl)cnc2[nH]1. References: Chan F, et al. Mol Cancer Ther. 2007, 6(12), 3147-3157.
Supplier: TargetMol
Supplier-Nr: T6435

Properties

Application: Aurora kinase inhibitor
MW: 497.02 D
Formula: C23H25ClN8OS

Database Information

CAS : 942947-93-5| Matching products
KEGG ID : K11479 | Matching products

Handling & Safety

Storage: -20°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "CCT129202"
Write a review
or to review a product.
Viewed